Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Serum interleukin-6 concentration in patients with pemphigus

Thai Van Thanh Le, Anh Tuan Ngo, Quoc Hung Ta, The Bich Thanh Vuong

01-02-2024

https://doi.org/10.4081/dr.2024.9868

837

PDF: 445

HTML: 19
Autoinflammatory diseases: what is behind them and what is new?

Michele Maalouly, Serena Saade, Mazen Kurban

29-12-2022

https://doi.org/10.4081/dr.2023.9625

1779

PDF: 560

HTML: 138
Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

Fitri Kadarsih Banjar, Farida Tabri, Sri Vitayani Muchtar, Mochammad Hatta, Khaeruddin Djawad, Farida Ilyas, Sitti Musafirah, Muhammad Nasrum Massi, Agussalim Bukhari, Andi Alfian Zainuddin

12-09-2023

https://doi.org/10.4081/dr.2023.9773

913

PDF: 464

HTML: 18
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

742

PDF: 365

HTML: 27
Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

Trang Thi Thuy Le, Thang Tat Nguyen, Chuyen Thi Hong Nguyen, Hao Trong Nguyen, Trung The Van

27-10-2021

https://doi.org/10.4081/dr.2021.9398

3119

PDF: 575

HTML: 9
Neutrophilic urticarial dermatosis without systemic disease: case report

Sukaina Al Haddad, Abdulrahman Alfawzan, Maisa Alfalah , Manea Alharbi

30-01-2024

https://doi.org/10.4081/dr.2024.9756

960

PDF: 728

HTML: 36
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1056

PDF: 546

HTML: 19
Atopic dermatitis: a brief review of recent advances in its management

Sultan Daghafak Alenazi

23-05-2023

https://doi.org/10.4081/dr.2023.9678

2387

PDF: 1409

HTML: 106
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

1157

PDF: 655

HTML: 27
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2682

PDF: 982

HTML: 31
Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

Ayumi Sato, Takeshi Fukumoto, Ai Yoshioka, Chikako Nishigori

27-10-2022

https://doi.org/10.4081/dr.2022.9567

990

PDF: 514

HTML: 15
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1137

PDF: 620

HTML: 20
Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup

17-12-2015

https://doi.org/10.4081/dr.2015.6246

3152

PDF: 945

HTML: 752
Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

22-05-2023

https://doi.org/10.4081/dr.2023.9630

1057

PDF: 563

HTML: 73
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

627

PDF: 372

HTML: 16
Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

Le Thai Van Thanh, Le Vi Anh, Tran Huong Giang, Ta Quoc Hung, Van The Trung, Nguyen Lam Vuong

17-03-2022

https://doi.org/10.4081/dr.2022.9444

1109

PDF: 598

HTML: 24
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1306

PDF: 405

HTML: 45
Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Casey E. Watkins, Winston B. Bokor, Stuart Leicht, George Youngberg, Guha Krishnaswamy

e12

29-07-2011

https://doi.org/10.4081/dr.2011.e12

11685

PDF: 2218

HTML: 2302
Mendelian randomization analysis of the causal relationship between immune cells and keloid

Jingwen Zou, Pengkhun Nov, Kunpeng Du

23-10-2024

https://doi.org/10.4081/dr.2024.10106

722

PDF: 391

SUPPLEMENTARY MATERIAL: 141

HTML: 12
The role of protein-53 amyloid in determining the aggressiveness of basal cell carcinoma regulated by interleukin-6, myeloid cell leukemia-1 and basic fibroblast growth factor

Prasetyadi Mawardi, Handono Kalim, Kusworini Handono Kalim, Loeki Enggar Fitri, Karyono Mintarjo, Ambar Mudigdo, Oyong Oyong, Brian Wasita

29-03-2019

https://doi.org/10.4081/dr.2019.8012

1278

PDF: 506
Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Pati Aji Achdiat, Stephanie Widjaja, Oki Suwarsa, Reiva Farah Dwiyana, Reti Hindritiani, Endang Sutedja, Hendra Gunawan, Hermin Aminah Usman, Fathia Rianty, Retno Hesty Maharani

30-01-2024

https://doi.org/10.4081/dr.2024.9754

880

PDF: 536

HTML: 26
Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

21-11-2022

https://doi.org/10.4081/dr.2022.9469

1302

PDF: 548

HTML: 34
Refractory pityriasis rubra pilaris treated with abrocitinib

Filip Rob

09-01-2025

https://doi.org/10.4081/dr.2025.10105

404

PDF: 273

HTML: 11
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1371

PDF: 661

HTML: 142
Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

Anna Paola Lugli, Niccolò Gori, Elena Ippoliti, Benedetta Ambrosio, Ketty Peris

03-02-2026

https://doi.org/10.4081/dr.2026.10644

520

PDF: 298

1 - 25 of 95 items 1 2 3 4 > >>

Search

Search Results

Serum interleukin-6 concentration in patients with pemphigus

Autoinflammatory diseases: what is behind them and what is new?

Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata

Neutrophilic urticarial dermatosis without systemic disease: case report

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Atopic dermatitis: a brief review of recent advances in its management

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Implications of interleukin-17 in psoriatic lesions as Koebner phenomenon caused by recurrent occupational burns

Erythrodermic psoriasis improved by tildrakizumab

Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Immunohistochemical expression of interleukin β in papule biopsies from patients with acne vulgaris

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Telangiectasia Macularis Eruptiva Perstans: more than skin deep

Mendelian randomization analysis of the causal relationship between immune cells and keloid

The role of protein-53 amyloid in determining the aggressiveness of basal cell carcinoma regulated by interleukin-6, myeloid cell leukemia-1 and basic fibroblast growth factor

Effectiveness and safety of tuberculin purified protein derivative for the treatment of anogenital warts in patients with human immunodeficiency virus

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Refractory pityriasis rubra pilaris treated with abrocitinib

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Upadacitinib as a potential option for the management of paradoxical eczema induced by interleukin-23 inhibitors

authors

reviewers

Categories

indexing

dermatopathology